FDA yo improve the pipeline on non-addictive treatments for pain.
Rexlemestrocel-L for the treatment of CLBP & not only that, but the reduction in public use of opioids.
Adcoms….advisory committees play a crucial role in regulatory decision-making….
9-1 YES Vote for Remestemcel-L in the treatment of children dying of sr-aGVHD.
All for transparency!
Ann: Mesoblast Completes Resubmission of BLA to FDA for SR-aGVHD, page-527
-
- There are more pages in this discussion • 388 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
92.5¢ |
Change
0.010(1.09%) |
Mkt cap ! $1.056B | |||
| Open | High | Low | Value | Volume |
| 90.5¢ | 94.0¢ | 89.5¢ | $4.970M | 5.436M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 18877 | 92.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 92.5¢ | 6795 | 1 |
View Market Depth
| Last trade - 16.10pm 08/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |